These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 38158963)
1. [Study of urinary markers of different podocytopathies by proteomic analysis]. Vinogradov AA; Chebotareva NV; Bugrova AE; Brzhozovskiy AG; Krasnova TN; Nasibullina KZ; Kononikhin AS; Moiseev SV Ter Arkh; 2023 Aug; 95(6):457-461. PubMed ID: 38158963 [TBL] [Abstract][Full Text] [Related]
2. Potential Urine Proteomic Biomarkers for Focal Segmental Glomerulosclerosis and Minimal Change Disease. Chebotareva NV; Vinogradov A; Brzhozovskiy AG; Kashirina DN; Indeykina MI; Bugrova AE; Lebedeva M; Moiseev S; Nikolaev EN; Kononikhin AS Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293475 [TBL] [Abstract][Full Text] [Related]
3. Focal and Segmental Glomerulosclerosis and Membranous Nephropathy overlapping in a patient with Nephrotic Syndrome: a case report. Silva CAD; Custódio FB; Monteiro MLGDR; Araújo SA; Araújo LS; Côrrea RRM; Reis MAD; Machado JR J Bras Nefrol; 2020 Mar; 42(1):113-117. PubMed ID: 30806447 [TBL] [Abstract][Full Text] [Related]
4. Proteomic Analysis of Idiopathic Nephrotic Syndrome Triggered by Primary Podocytopathies in Adults: Regulatory Mechanisms and Diagnostic Implications. Chen Q; Xu J; Liu L; Ye Q; Lin W; Liao Y; Gao R; Zhang X; Chen R; Xiong Y; Chen S; Ye X; Wei L J Proteome Res; 2024 Jun; 23(6):2090-2099. PubMed ID: 38728052 [TBL] [Abstract][Full Text] [Related]
5. Comparative differential proteomic analysis of minimal change disease and focal segmental glomerulosclerosis. Pérez V; López D; Boixadera E; Ibernón M; Espinal A; Bonet J; Romero R BMC Nephrol; 2017 Feb; 18(1):49. PubMed ID: 28158993 [TBL] [Abstract][Full Text] [Related]
6. [Nephrotic syndrom with focal and segmental glomerulosclerosis in Dakar: epidemiological and clinicopathological characteristics (about 134 cases)]. Niang A; Dial C; Ka EF; Lèye A; Pouye A; Ka MM; Mbengue M; Droz D; Diouf B Dakar Med; 2008; 53(1):45-51. PubMed ID: 19102117 [TBL] [Abstract][Full Text] [Related]
7. Plasma microRNA-186 and proteinuria in focal segmental glomerulosclerosis. Zhang C; Zhang W; Chen HM; Liu C; Wu J; Shi S; Liu ZH Am J Kidney Dis; 2015 Feb; 65(2):223-32. PubMed ID: 25218681 [TBL] [Abstract][Full Text] [Related]
8. Differentially expressed urinary biomarkers in children with idiopathic nephrotic syndrome. Suresh CP; Saha A; Kaur M; Kumar R; Dubey NK; Basak T; Tanwar VS; Bhardwaj G; Sengupta S; Batra VV; Upadhyay AD Clin Exp Nephrol; 2016 Apr; 20(2):273-83. PubMed ID: 26351173 [TBL] [Abstract][Full Text] [Related]
9. Urinary podocytes in primary focal segmental glomerulosclerosis. Hara M; Yanagihara T; Kihara I Nephron; 2001 Nov; 89(3):342-7. PubMed ID: 11598401 [TBL] [Abstract][Full Text] [Related]
10. Urine biomarkers predict the cause of glomerular disease. Varghese SA; Powell TB; Budisavljevic MN; Oates JC; Raymond JR; Almeida JS; Arthur JM J Am Soc Nephrol; 2007 Mar; 18(3):913-22. PubMed ID: 17301191 [TBL] [Abstract][Full Text] [Related]
11. Diagnosis and treatment of primary glomerular diseases. Membranous nephropathy, focal segmental glomerulosclerosis and IgA nephropathy. Deegens JK; Wetzels JF Minerva Urol Nefrol; 2005 Sep; 57(3):211-36. PubMed ID: 15986018 [TBL] [Abstract][Full Text] [Related]
12. Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis. Bazzi C; Petrini C; Rizza V; Arrigo G; Napodano P; Paparella M; D'Amico G Nephrol Dial Transplant; 2002 Nov; 17(11):1890-6. PubMed ID: 12401843 [TBL] [Abstract][Full Text] [Related]
13. Characterization of proteinuria in primary glomerulonephritides: urinary polymers of albumin. Bazzi C; Petrini C; Rizza V; Arrigo G; Beltrame A; D'Amico G Am J Kidney Dis; 1997 Sep; 30(3):404-12. PubMed ID: 9292570 [TBL] [Abstract][Full Text] [Related]
14. Comparative proteomic analysis of children FSGS FFPE tissues. Ni J; Tian S; Bai L; Lv Q; Liu J; Liu J; Fang Y; Zhai Y; Shen Q; Rao J; Ding C; Xu H BMC Pediatr; 2022 Dec; 22(1):707. PubMed ID: 36503536 [TBL] [Abstract][Full Text] [Related]
15. Predictive urinary biomarkers for steroid-resistant and steroid-sensitive focal segmental glomerulosclerosis using high resolution mass spectrometry and multivariate statistical analysis. Kalantari S; Nafar M; Rutishauser D; Samavat S; Rezaei-Tavirani M; Yang H; Zubarev RA BMC Nephrol; 2014 Sep; 15():141. PubMed ID: 25182141 [TBL] [Abstract][Full Text] [Related]
16. Focal segmental glomerulosclerosis, excluding atypical lesion, is a predictor of renal outcome in patients with membranous nephropathy: a retrospective analysis of 716 cases. He HG; Wu CQ; Ye K; Zeng C; Huang YY; Luo SW; Yin W; Ye QR; Peng XM BMC Nephrol; 2019 Aug; 20(1):328. PubMed ID: 31438882 [TBL] [Abstract][Full Text] [Related]
17. Clinical and pathological features of idiopathic membranous nephropathy with focal segmental sclerosis. Li J; Chen B; Gao C; Huang J; Wang Y; Zhang S; Xu Y; Guo W; Wang R BMC Nephrol; 2019 Dec; 20(1):467. PubMed ID: 31842785 [TBL] [Abstract][Full Text] [Related]
18. Focal segmental glomerulosclerosis is not a sufficient predictor of renal outcome in patients with membranous nephropathy. Heeringa SF; Branten AJ; Deegens JK; Steenbergen E; Wetzels JF Nephrol Dial Transplant; 2007 Aug; 22(8):2201-7. PubMed ID: 17442739 [TBL] [Abstract][Full Text] [Related]
19. Urinary soluble HLA class I antigen in patients with minimal change disease: a predictor of steroid response. Park CW; Song HC; Shin YS; Ahn SJ; Kim YS; Kim SY; Choi EJ; Chang YS; Bang BK Nephron; 1998; 79(1):44-9. PubMed ID: 9609461 [TBL] [Abstract][Full Text] [Related]
20. Mycophenolate mofetil or standard therapy for membranous nephropathy and focal segmental glomerulosclerosis: a pilot study. Senthil Nayagam L; Ganguli A; Rathi M; Kohli HS; Gupta KL; Joshi K; Sakhuja V; Jha V Nephrol Dial Transplant; 2008 Jun; 23(6):1926-30. PubMed ID: 17989103 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]